Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRTTSE:6034 -0.95%63 Shareholder Yield % is 9.07% as of Mar. 2026, which is 90600% above its 10-year median of 0.01. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円630.64 (Fairly Valued). The stock has 4 warning signs investors should review. Among 653 Healthcare Providers & Services companies, MRT ranks better than 87.29% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, MRT's Shareholder Yield % was 9.07%.
MRT (TSE:6034) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
MRT Shareholder Yield % Related Terms
MRT Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for MRT's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6034 vs HCA, THC, DVA: Shareholder Yield % Comparison
For the Medical Care Facilities subindustry, MRT's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRT Shareholder Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRT's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where MRT's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
MRT (TSE:6034) has a Shareholder Yield % of 9.07% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on MRT and its competitors. This is 90600% above median its historical median of 0.01. According to the industry distribution chart, MRT ranks #83 out of 653 companies in the Healthcare Providers & Services industry, placing it in the top 12.7%.
Is MRT's Shareholder Yield % too high?
MRT's current Shareholder Yield % of 9.07% is 90600% above median its 10-year median of 0.01. The Healthcare Providers & Services industry median Shareholder Yield % is 0.08. MRT's value of 9.07% is 11237.5% above this industry median. Based on the distribution chart, MRT ranks #83 out of 653 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Shareholder Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MRT ranks #83 out of 653 companies for Shareholder Yield %. This places MRT in the top 13% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.08. MRT's value of 9.07% is 11237.5% above this benchmark. While the company's 10-year median is 0.01 vs. the industry median of 0.08, MRT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.08, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MRT's current Shareholder Yield % of 9.07% is 11237.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on MRT and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRT's current Shareholder Yield % is 9.07%, which is 90600% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円630.64, compared to a current price of 円624.00 — trading 1.1% below its estimated fair value. The current Shareholder Yield % is 9.07%, which is 90600% above median its 10-year median of 0.01 and 11237.5% above the Healthcare Providers & Services industry median of 0.08. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For MRT (TSE:6034), the current Shareholder Yield % is 9.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRT (TSE:6034) Overvalued in 2026?
Based on GuruFocus' analysis, MRT stock appears to be undervalued.
The current stock price of 円624.00 is trading 1.1% below its estimated GF Value™ of 円630.64.
GuruFocus considers MRT to be Fairly Valued.
Key valuation signals for TSE:6034:
Shareholder Yield %: 9.07% (90600% above median its 10-year median of 0.01)
GF Value™: 円630.64 vs. price of 円624.00 (1.1% below fair value)
Industry Position: 11237.5% above the Healthcare Providers & Services median (#83 of 653)
No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score
Get the complete analysis for TSE:6034
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6034 has been successfully added to your 
